Literature DB >> 15332329

Intracranial and spinal melanotic schwannoma in the same patient.

Ralf Buhl1, Harald Barth, Heinz H Hugo, Victor F Mautner, H Maximilian Mehdorn.   

Abstract

Melanotic schwannoma is a nerve sheath tumor composed of melanin - producing cells with ultrastructural features of Schwann cells, which is very rare. These tumors can appear intracranially and less common in the spinal canal. The prognosis is usually good although cases with metastases and death are described in the literature. We present the unusual and rare case of a young man with a spinal melanotic schwannoma at L5/S1 who presented 30 months later with an intracranial melanotic schwannoma.

Entities:  

Mesh:

Year:  2004        PMID: 15332329     DOI: 10.1023/b:neon.0000033491.23654.6c

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  12 in total

1.  Two rare lumbar tumours with unusual MRI characteristics.

Authors:  I Aprile; C A Scott; D Cervesato; C A Beltrami; A Meo; G Fabris
Journal:  Neuroradiology       Date:  2000-06       Impact factor: 2.804

Review 2.  Neurosurgical implications of Carney complex.

Authors:  J C Watson; C A Stratakis; P K Bryant-Greenwood; C A Koch; L S Kirschner; T Nguyen; J A Carney; E H Oldfield
Journal:  J Neurosurg       Date:  2000-03       Impact factor: 5.115

3.  Melanotic nerve sheath tumors.

Authors:  T I Mandybur
Journal:  J Neurosurg       Date:  1974-08       Impact factor: 5.115

4.  Spinal melanotic schwannoma: a tumour with poor prognosis.

Authors:  A V Vallat-Decouvelaere; M Wassef; G Lot; M Catala; M Moussalam; N Caruel; J Mikol
Journal:  Histopathology       Date:  1999-12       Impact factor: 5.087

5.  Melanotic schwannoma of the spinal cord.

Authors:  J B Gregorios; S M Chou; J Bay
Journal:  Neurosurgery       Date:  1982-07       Impact factor: 4.654

Review 6.  Intramedullary melanotic schwannoma. Report of a case and review of the literature.

Authors:  N Acciarri; R Padovani; L Riccioni
Journal:  Br J Neurosurg       Date:  1999-06       Impact factor: 1.596

7.  Meningeal melanocytoma: an aggressive course for a benign tumor.

Authors:  Ali Bydon; Jorge A Gutierrez; Asim Mahmood
Journal:  J Neurooncol       Date:  2003-09       Impact factor: 4.130

8.  Intramedullary melanotic schwannoma of the cervicomedullary junction.

Authors:  R A Solomon; M S Handler; R V Sedelli; B M Stein
Journal:  Neurosurgery       Date:  1987-01       Impact factor: 4.654

Review 9.  Melanocytic schwannoma.

Authors:  R M Killeen; C L Davy; S C Bauserman
Journal:  Cancer       Date:  1988-07-01       Impact factor: 6.860

10.  Intracerebellar melanotic schwannoma: a case report.

Authors:  A Ranjan; G Chacko; S M Chandi
Journal:  Br J Neurosurg       Date:  1995       Impact factor: 1.596

View more
  5 in total

1.  Intracranial melanotic schwannomas: a rare variant with unusual adherent features.

Authors:  D Mahato; T Vivas-Buitrago; K Gassie; M Jentoft; D Tavanaiepour; A Quiñones-Hinojosa
Journal:  J Neurooncol       Date:  2017-11-02       Impact factor: 4.130

2.  Extramedullary malignant melanotic schwannoma of the spine: Case report and an up to date systematic review of the literature.

Authors:  Georgios Solomou; Adikarige Haritha Dulanka Silva; Adrianna Wong; Ute Pohl; Nikolaos Tzerakis
Journal:  Ann Med Surg (Lond)       Date:  2020-10-07

Review 3.  Melanotic schwannoma: an 11-year case series.

Authors:  Michael Khoo; Ian Pressney; Rikin Hargunani; Roberto Tirabosco
Journal:  Skeletal Radiol       Date:  2015-09-19       Impact factor: 2.199

4.  Malignant psammomatous melanotic schwannoma of the spine: A component of Carney complex.

Authors:  Lisa B E Shields; Steven D Glassman; George H Raque; Christopher B Shields
Journal:  Surg Neurol Int       Date:  2011-09-30

Review 5.  Dorsal dumb-bell melanotic schwannoma operated on by posterior and anterior approach: case report and a review of the literature.

Authors:  Leonardo De Cerchio; Filiberto Contratti; Mario F Fraioli
Journal:  Eur Spine J       Date:  2006-09-01       Impact factor: 3.134

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.